BLGO · Biolargo, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“The foregoing factors raise substantial doubt about our ability to continue as a going concern, unless we are able to increase revenues, generate cash from operations, and/or generate cash from financing activities.”View the 10-Q filed May 15, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-07 | CODE KENNETH REAY |
Director, Chief Science Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The shares issued are subject to a Lock-Up Agreement dated as of the issuance date whereby shares are locked-up and restricted from sale until the Issuer reports gross revenue of at least $40 million on a consolidated basis for any reported period (e.g, quarter or annual), or the Issuer's market capitalization exceeds $300 million, or there is a "change in control" in the Issuer. Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share). Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation. |
Common Stock
|
532,567 |
| 2026-07-01 | CALVERT DENNIS P |
Director, President |
Award↑
Filing footnotes — Common Stock (Direct)
The shares issued are subject to a Lock-Up Agreement dated as of the issuance date whereby shares are locked-up and restricted from sale until the Issuer reports gross revenue of at least $40 million on a consolidated basis for any reported period (e.g, quarter or annual), or the Issuer's market capitalization exceeds $300 million, or there is a "change in control" in the Issuer. Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares issued and the acquisition price per share). Includes 1,528,695 shares owned indirectly by Reporting Person through a limited liability company owned and controlled by Reporting Person. |
Common Stock
|
219,914 |
| 2026-06-30 | Marshall Dennis E |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was granted to Reporting Person to replace an option to purchase 22,500 shares that had been issued to compensate Reporting Person for services to the Issuer and had expired unexercised due to a discrepancy between the original exercise price and Issuer's current stock price, pursuant to plan adopted by the Issuer's Compensation Committee. Total reflects the expiration of options to purchase 22,500 shares that expired June 30, 2026. |
Option to Purchase Common Stock
|
198,238 |
| 2026-06-30 | CALVERT DENNIS P |
Director, President |
Award↑
Filing footnotes — Common Stock (Direct)
The shares issued are subject to a Lock-Up Agreement dated as of the issuance date whereby shares are locked-up and restricted from sale until the Issuer reports gross revenue of at least $40 million on a consolidated basis for any reported period (e.g, quarter or annual), or the Issuer's market capitalization exceeds $300 million, or there is a "change in control" in the Issuer. Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares issued and the acquisition price per share). Includes 1,528,695 shares owned indirectly by Reporting Person through a limited liability company owned and controlled by Reporting Person. |
Common Stock
|
699,569 |
| 2026-06-30 | Marshall Dennis E |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. The number of shares in the Option is equal to the amount of fees due divided by the exercise price of the Option. |
Option to Purchase Common Stock
|
115,741 |
| 2026-06-30 | Bray Christina Elaine |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. The number of shares in the Option is equal to the amount of fees due divided by the exercise price of the Option. |
Option to Purchase Common Stock
|
165,198 |
| 2026-06-30 | Park Linda |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. The number of shares in the Option is equal to the amount of fees due divided by the exercise price of the Option. |
Option to Purchase Common Stock
|
165,198 |
| 2026-06-30 | STROMMEN JACK B. |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $15,000 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. The number of shares in the Option is equal to the amount of fees due divided by the exercise price of the Option. |
Option to Purchase Common Stock
|
132,159 |
| 2026-06-22 | Marshall Dennis E |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was granted to Reporting Person to replace an option to purchase 10,000 shares that had been issued to compensate Reporting Person for services on the board of directors to the Issuer and had expired unexercised due to a discrepancy between the original exercise price and Issuer's current stock price, pursuant to plan adopted by the Issuer's Compensation Committee. Total reflects the expiration of options to purchase 10,000 shares that expired June 20, 2026. |
Option to Purchase Common Stock
|
40,909 |
| 2026-03-31 | CODE KENNETH REAY |
Director, Chief Science Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The shares issued are subject to a Lock-Up Agreement dated as of the issuance date whereby shares are locked-up and restricted from sale until the Issuer reports gross revenue of at least $40 million on a consolidated basis for any reported period (e.g, quarter or annual), or the Issuer's market capitalization exceeds $300 million, or there is a "change in control" in the Issuer. Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share). Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation. |
Common Stock
|
69,444 |
| 2026-03-31 | Marshall Dennis E |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was granted to Reporting Person to replace an option to purchase 68,182 shares that had been issued to compensate Reporting Person for $22,500 in services to the Issuer and had expired unexercised due to a discrepancy between the original exercise price and Issuer's current stock price, pursuant to plan adopted by the Issuer's Compensation Committee. Total reflects the expiration of options to purchase 68,182 shares that expired March 31, 2026. |
Option to Purchase Common Stock
|
138,889 |
| 2026-03-31 | Park Linda |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. The number of shares in the Option is equal to the amount of fees due divided by the exercise price of the Option. |
Option to Purchase Common Stock
|
115,741 |
| 2026-03-31 | Marshall Dennis E |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. The number of shares in the Option is equal to the amount of fees due divided by the exercise price of the Option. |
Option to Purchase Common Stock
|
115,741 |
| 2026-03-31 | Bray Christina Elaine |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. The number of shares in the Option is equal to the amount of fees due divided by the exercise price of the Option. |
Option to Purchase Common Stock
|
115,741 |
| 2026-03-31 | STROMMEN JACK B. |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $15,000 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. The number of shares in the Option is equal to the amount of fees due divided by the exercise price of the Option. |
Option to Purchase Common Stock
|
92,593 |
| 2026-02-01 | DARGAN CHARLES K |
Chief Financial Officer |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to the Reporting Person as compensation to serve as Issuer's Chief Financial Officer from February 1, 2026, through January 31, 2027. |
Option to Purchase Common Stock
|
300,000 |
| 2025-12-31 | Park Linda |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
101,736 |
| 2025-12-31 | Bray Christina Elaine |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
101,736 |
| 2025-12-31 | Marshall Dennis E |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
101,736 |
| 2025-12-31 | STROMMEN JACK B. |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $15,000 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
81,389 |
| 2025-12-31 | CALVERT DENNIS P |
Director, President |
Award↑
Filing footnotes — Common Stock (Direct)
The shares issued are subject to a Lock-Up Agreement dated as of the issuance date whereby shares are locked-up and restricted from sale until the Issuer reports gross revenue of at least $40 million on a consolidated basis for any reported period (e.g, quarter or annual), or the Issuer's market capitalization exceeds $300 million, or there is a "change in control" in the Issuer. Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares issued and the acquisition price per share). Includes 1,528,695 shares owned indirectly by Reporting Person through a limited liability company owned and controlled by Reporting Person. |
Common Stock
|
130,222 |
| 2025-12-31 | CODE KENNETH REAY |
Director, Chief Science Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The shares issued are subject to a Lock-Up Agreement dated as of the issuance date whereby shares are locked-up and restricted from sale until the Issuer reports gross revenue of at least $40 million on a consolidated basis for any reported period (e.g, quarter or annual), or the Issuer's market capitalization exceeds $300 million, or there is a "change in control" in the Issuer. Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share). Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation. |
Common Stock
|
54,803 |
| 2025-12-31 | Marshall Dennis E |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was granted to Reporting Person to replace an option to purchase 45,000 shares that had been issued to compensate Reporting Person for $22,500 in services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and Issuer's current stock price, pursuant to plan adopted by the Issuer's Compensation Committee. Total reflects the expiration of options to purchase 45,000 shares that recently expired. |
Option to Purchase Common Stock
|
122,084 |
| 2025-11-14 | CODE KENNETH REAY |
Director, Chief Science Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The shares issued are subject to a Lock-Up Agreement dated as of the issuance date whereby shares are locked-up and restricted from sale until the Issuer reports gross revenue of at least $40 million on a consolidated basis for any reported period (e.g, quarter or annual), or the Issuer's market capitalization exceeds $300 million, or there is a "change in control" in the Issuer. Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share). Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation. |
Common Stock
|
313,754 |
| 2025-11-14 | CALVERT DENNIS P |
Director, President |
Award↑
Filing footnotes — Common Stock (Direct)
The shares issued are subject to a Lock-Up Agreement dated as of the issuance date whereby shares are locked-up and restricted from sale until the Issuer reports gross revenue of at least $40 million on a consolidated basis for any reported period (e.g, quarter or annual), or the Issuer's market capitalization exceeds $300 million, or there is a "change in control" in the Issuer. Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares issued and the acquisition price per share). Includes 1,528,695 shares owned indirectly by Reporting Person through a limited liability company owned and controlled by Reporting Person. |
Common Stock
|
310,269 |
| 2025-09-30 | Park Linda |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
110,294 |
| 2025-09-30 | STROMMEN JACK B. |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $15,000 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
88,235 |
| 2025-09-30 | Marshall Dennis E |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
110,294 |
| 2025-09-30 | Bray Christina Elaine |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
110,294 |
| 2025-09-30 | Marshall Dennis E |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was granted to Reporting Person to replace an option to purchase 34,615 shares that had been issued to compensate Reporting Person for $22,500 in services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and Issuer's current stock price, pursuant to plan adopted by the Issuer's Compensation Committee. Total reflects the expiration of options to purchase 34,615 shares that recently expired. |
Option to Purchase Common Stock
|
132,351 |
| 2025-07-14 | CALVERT DENNIS P |
Director, President |
Award↑
Filing footnotes — Common Stock (Direct)
The shares issued are subject to a Lock-Up Agreement dated as of the issuance date whereby shares are locked-up and restricted from sale until the Issuer reports gross revenue of at least $40 million on a consolidated basis for any reported period (e.g, quarter or annual), or the Issuer's market capitalization exceeds $300 million, or there is a "change in control" in the Issuer. Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares issued and the acquisition price per share). Includes 1,528,695 shares owned indirectly by Reporting Person through a limited liability company owned and controlled by Reporting Person. |
Common Stock
|
169,498 |
| 2025-07-14 | CODE KENNETH REAY |
Director, Chief Science Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share). Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation. |
Common Stock
|
181,253 |
| 2025-06-30 | Marshall Dennis E |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was granted to Reporting Person to replace an option to purchase 10,000 shares that had been issued to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and Issuer's current stock price, pursuant to plan adopted by the Issuer's Compensation Committee. Total reflects the expiration of options to purchase 10,000 shares that recently expired. |
Option to Purchase Common Stock
|
19,000 |
| 2025-06-30 | Bray Christina Elaine |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
93,750 |
| 2025-06-30 | Marshall Dennis E |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
93,750 |
| 2025-06-30 | STROMMEN JACK B. |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $15,000 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
75,000 |
| 2025-06-30 | Park Linda |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
93,750 |
| 2025-06-30 | Marshall Dennis E |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was granted to Reporting Person to replace an option to purchase 64,286 shares that had been issued to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and Issuer's current stock price, pursuant to plan adopted by the Issuer's Compensation Committee Total reflects the expiration of options to purchase 64,286 shares that recently expired. |
Option to Purchase Common Stock
|
112,501 |
| 2024-12-31 | Bray Christina Elaine |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
98,684 |
| 2024-12-31 | STROMMEN JACK B. |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $15,000 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
78,947 |
| 2024-12-31 | Park Linda |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
98,684 |
| 2024-12-31 | CODE KENNETH REAY |
Director, Chief Science Officer |
Award↑
Filing footnotes — Common stock (Direct)
Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share). Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation. |
Common stock
|
57,666 |
| 2024-12-31 | Marshall Dennis E |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
98,684 |
| 2024-12-26 | Marshall Dennis E |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was granted to Reporting Person to replace an option to purchase 64,286 shares that had been issued to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee. Total reflects the expiration of options to purchase 64,286 shares that recently expired. |
Option to Purchase Common Stock
|
118,422 |
| 2024-09-30 | Park Linda |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
81,522 |
| 2024-09-30 | Marshall Dennis E |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
81,522 |
| 2024-09-30 | STROMMEN JACK B. |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $15,000 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
65,217 |
| 2024-09-30 | Bray Christina Elaine |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan. |
Option to Purchase Common Stock
|
81,522 |
| 2024-09-29 | Marshall Dennis E |
Director |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
This Option was granted to Reporting Person to replace an option to purchase 47,872 shares that had been issued to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee. Total reflects the expiration of options to purchase 47,872 shares that recently expired. |
Option to Purchase Common Stock
|
93,749 |
| 2024-08-13 | DARGAN CHARLES K |
Chief Financial Officer |
Award↑
Filing footnotes — Option (Direct)
This Option was issued to the Reporting Person as compensation to serve as Issuer's Chief Financial Officer from February 1, 2024, through January 31, 2025. The Option vests in equal monthly installments of 25,000 shares, so long as the Engagement Extension Agreement dated August 13, 2024, between Reporting Person and Issuer, remains in force and effect. |
Option
|
300,000 |